3.93
3.93 (0%)
As of Feb 14, 2025
Orasure Technologies Inc [OSUR]
Source:
Company Overview
Orasure Technologies Inc consists of the development, manufacture, marketing and sale of simple, easy to use diagnostic products and specimen collection devices using the Company's proprietary technologies, as well as other diagnostic products including immunoassays and other in vitro diagnostic tests that are used on other specimen types.
| Country | United States |
| Headquarters | bethlehem, pennsylvania |
| Phone Number | (610) 882-1820 |
| Industry | manufacturing |
| CEO | Carrie Eglinton Manner |
| Website | www.oraquick.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $185.8 |
| Operating Profit | $-28.3 |
| Net Income | $-19.5 |
| Net Cash | $-22.6 |
Profit Ratios
| Gross Margin | $79.4 |
| Operating Margin | -15.2 |
| Profit as % of Revenues | -407.1% |
| Profit as % of Assets | -4.1% |
| Profit as % of Stockholder Equity | -4.8% |
Management Effectiveness
| Return on Equity | -4.8% |
| Return on Assets | -4.1% |
| Turnover Ratio | 38.6% |
| EBITA | $-28.3 |
Balance Sheet and Cash Flow Measures
| Total Assets | $479.7 |
| Total Liabilities | $69.3 |
| Operating Cash Flow | $27.4 |
| Investing Cash Flow | $-39 |
| Financing Cash Flow | $-4.2 |
